OYO Assets, the hotel acquisition and development platform backed by PRISM, has secured INR 125 crore in fresh funding from a group of institutional and private investors, with the round led by InCred. The company said the new investment will accelerate its expansion strategy across India, particularly in the premium and mid-premium segments.

Also known as Sunday PropTech, OYO Assets focuses on identifying and upgrading hotel properties in markets driven by both leisure and business travel. The firm intends to use the capital to deepen its search for well-priced hospitality assets and enhance its asset-management capabilities as it scales up operations.

Commenting on the performance of the platform, Saurabh Jhalaria, Chief Investment Officer at InCred, said its track record highlights the strength of its strategy. He noted that the portfolio has shown resilience, steady cash flows and clear unit level profitability. According to him, these trends reflect growing interest from organised capital in India’s hospitality sector.

Jhalaria added that Sunday PropTech’s approach has set it apart in a competitive market. He said the latest investment will support the platform as it pursues high quality hotel assets while maintaining financial discipline.

OYO Assets plans to acquire 12 hotels in the current financial year, with seven transactions already in advanced stages. Once completed, the properties will operate under PRISM-owned brands including Sunday Hotels, Palette Hotels, Townhouse, as well as select United States-based brands.

This latest round follows an earlier INR 50 crore investment in September from InCred and an Analah-led consortium, adding further momentum to the company’s expansion pipeline. The firm’s wider growth push reflects rising domestic travel demand and increasing investor appetite for hospitality-led real-estate platforms.

With its strengthened capital position, OYO Assets is expected to widen its reach across India’s key destinations, building a larger portfolio designed to deliver consistent returns and long-term stability.